Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Conditions:   Metastatic Melanoma;   Squamous Cell Carcinoma of the Head and Neck;   Non-small Cell Lung Cancer
Interventions:   Biological: Lifileucel;   Biological: LN-145;   Drug: Pembrolizumab
Sponsor:   Iovance Biotherapeutics, Inc.
Not yet recruiting

https://ift.tt/2P06pco